(redirected from amylin)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Related to amylin: Symlin
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to dextrin

any of various polysaccharides obtained by hydrolysis of starch

References in periodicals archive ?
Insulin (Genway), amylin (Millipore), S100B (Millipore), sRAGE (R&D), and esRAGE (As One International) were quantified using ELISA per the manufacturer's protocol.
The trial was conducted jointly by the Duke Clinical Research Institute and the University of Oxford Diabetes Trial Unit, in collaboration with Amylin Pharmaceuticals.
He served as the president, chief executive officer and as a director of Amylin Pharmaceuticals, a biopharmaceutical company based in San Diego, California, focused on metabolic diseases, from March 2007 until it was acquired by the Bristol-Myers Squibb Co in August 2012.
Lutz, "The role of amylin in the control of energy homeostasis," The American Journal of Physiology--Regulatory Integrative and Comparative Physiology, vol.
By using Western blotting protocol, Amylin is shown to inhibit c-Fos expression following visceral pain.
Using AD models, the BUSM researchers investigated the effects of amylin on the pathogenesis of the disease.
In August 2012, federal prosecutors had charged Ramnarine with three counts of securities fraud, claiming he illegally made more than $300,000 from his investment in Amylin, as well as two other pharmaceutical companies Bristol-Myers was set to buy.
revenues were up 3%, due mainly to the inclusion of Amylin diabetes products and growth for Symbicort, Brilinta and Onglyza.
9 August 2012 - US pharmaceutical group Bristol-Myers Squibb Co (NYSE:BMY) said on Thursday it had finalised its acquisition of Amylin Pharmaceuticals Inc (NASDAQ:AMLN) for USD5.3bn (EUR4.3bn), plus assumption of around USD1.7bn of debt.
Bristol-Myers Squibb plans to use the net proceeds from the offering, along with the issuance of commercial paper and available cash, to fund its Amylin Pharmaceuticals Inc's acquisition and for general corporate purposes.
Even as Human Genome Sciences rejected GSK's extended tender as "not reflecting an accurate valuation," New York-based Bristol-Myers Squibb (NYSE: BMY) agreed to acquire San Diego diabetes drug-maker Amylin Pharmaceuticals (NASDAQ: AMLN) for $7 billion - the fourth billion-dollar plus deal and the largest in the pharmaceutical industry this year.
Albiglutide belongs to the same class of injectable GLP-1 medicines as Novo Nordisk's Victoza and Byetta, from Amylin Pharmaceuticals and Eli Lilly.
Their topics include a critical academic perspective on marketing antimicrobial peptides, conotoxin-based leads in drug design, kyotorphin derivatives as an example of turning endogenous peptides into new analgesics, sifuvirtide as a novel HIV-1 fusion inhibitor, translational research on amylin agonism, and developing antibody fragments for therapeutic applications.
There is also a deficiency in Amylin: A gluco regulatory peptide that is also cosecreted with insulin by the pancreatic a-cells.15 A recent study showed that over 84% of people with Type-2 diabetes experience significantly elevated post-meal glucose.16